Agilent technologies
Katarzyna Nazarewicz

Country manager

Katarzyna Nazarewicz

+48 797 701 027

Send Message

Agilent technologies

Trusted answers

Agilent is a privately owned biotechnology company pioneering in the development and commercialization of high-performance, cutting edge research instrumentation for life sciences. The mission is to transform cell analysis by providing innovative products and solutions to the research and drug discovery community.

 The first product for real-time, label-free cell-based assays based on a microelectronic readout was launched in 2004. Today, the company has a product line of several instruments which utilize this technology with different functionalities and throughputs, and enables different types of cell-based applications. xCELLigence  impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers product line are used in academic research worldwide. Citation of Agilent technologies is included in over 4000 peer reviewed publications from the pharmaceutical industry and academia is a testament to the success and uptake of this platforms in different life

Products

The RTCA DP Analyzer has three integrated stations for E-Plates 16 or CIM-Plates 16.

show detail

AccuWound 96 is a solution for a high-throughput scratch assays using 96 well plate.

show detail

Located inside a tissue culture incubator, it is capable of switching any one of the wells on any of six E-Plates to the RTCA Analyzer for impedance measurement.

show detail

The new CardioECR system combines impedance and Multi Electrode Array (MEA) technology with a pacing function.

show detail

Technologies supported by xCELLigence Cardio ECR – Agilent technologies